Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
Molecular Therapy - United States
doi 10.1016/j.ymthe.2018.10.016
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Elsevier BV